Benchmark says Semler Scientific could close valuation gap with Bitcoin treasury peers, sees 150% upside in SMLR
Quick Take Benchmark analysts initiated coverage on Semler Scientific’s stock with a “buy” rating and a $101 price target, suggesting about 150% upside from current levels. As of July 2, the healthtech company has amassed 4,636 BTC worth approximately $430 million at current prices.
It's been just over a year since Semler Scientific followed Strategy's lead to build out a corporate bitcoin treasury, which helped propel the stock from $22 a share to a high of $81 in December. Thanks in part to its new three-year plan, analysts at Benchmark say SMLR shares have more room to run.
Benchmark analysts led by Mark Palmer initiated coverage on Semler Scientific's stock with a "buy" rating and a $101 price target — or nearly 150% upside from the stock's current price level.
"We believe SMLR could close the gap between its relatively low mNAV and the higher mNAVs of other bitcoin treasury companies through a combination of execution, transparency, and investor engagement," Palmer wrote Tuesday in a note to clients. Last month, Semler Scientific announced the hiring of Joe Burnett as its new director of Bitcoin strategy, along with a three-year plan to own 105,000 bitcoin.
Using proceeds from equity and debt financings, as well as cash flows from operations, the Nasdaq-listed healthcare tech company plans to hold 10,000 BTC by the end of 2025, 42,000 BTC by year-end 2026, and 105,000 BTC by year-end 2027. In valuing SMLR shares, Benchmark has assumed bitcoin’s price will rise to $225,000 by the end of 2026.
Semler Scientific's multiple of net asset value (mNAV) of 1.25 trails those of Metaplanet and Blockchain Group at 4.29 and 6.45, respectively, according to Benchmark. Semler first announced its bitcoin treasury strategy in May 2024 and has achieved an approximately 294% BTC Yield (based on its total bitcoin holdings divided by the assumed diluted shares outstanding) through July 2.
Semler's healthcare business is a modest contributor to Benchmark's sum-of-the-parts valuation of its stock. Recent challenges include the overhang from a U.S. Department of Justice investigation, and Medicare reimbursement uncertainties may have contributed to the company’s mNAV discount.
"We believe the resolution of SMLR’s DOJ matter and its launch of CardioVanta, a SaaS-focused subsidiary aimed at expanding offerings in heart failure detection, could help to refocus its story and bolster its valuation," Palmer wrote in the note.
Semler shares traded higher by 8.5% to $42.28 at publication time, according to The Block's SMLR price data .
Semler Scientific was the second U.S. public company to adopt "the Bitcoin Standard," and there are now well over 200 firms that have adopted a bitcoin treasury strategy in some form, The Block previously reported .
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI investment enters the "Trough of Disillusionment", the next 18 months will be a life-or-death test!
Goldman Sachs believes that the AI investment cycle is currently in the "trough of disillusionment," but this is not the first time. The core contradiction lies in the fact that the business models of new cloud computing providers are highly dependent on end-user returns from AI spending, while currently "there are basically zero companies that can attribute profits to AI." Social Capital founder Palihapitiya has clearly defined an 18-month key window, during which the market will decide which AI business models are sustainable and which are not.

Anthropic's Core Concern: Revenue Can Be Withdrawn at Any Time, but Computing Power Costs Are Locked in for up to 20 Years
Zheshang Securities believes that Anthropic's revenue is mainly based on usage-based billing, with remaining performance obligations covering only about 5.1 months of annualized revenue, while compute power costs are already locked in with $895.4 billion in irrevocable commitments, some extending as far as 2045. Revenues can be reduced at any time, but costs are non-exitable, creating a highly asymmetric maturity gap between the two—this is the company's real core constraint.

Triple Pressure from the Federal Reserve, Treasury, and Congress; Goldman Sachs: Liquidity Crisis May Occur in 2027
Goldman Sachs warns that the reserve ratio of bank assets has dropped to around 11%, only slightly above the crisis trough of 2019. In the second half of 2027, a deadlock in debt ceiling negotiations will force the Treasury to rebuild the TGA, triggering a "perfect storm" of a sharp drop in reserves and a surge in T-bill supply; combined with stalled money market fund buying, this will create a huge liquidity black hole. The Federal Reserve could be forced into the awkward position of lowering interest rates and launching large-scale bond purchases to rescue the market.

